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Summary 
Sympathetic neurons, when placed in culture during 
the period of naturally occurring cell death, will die by 
apoptosis when deprived of nerve growth factor (NGF). 
In this system, the mRNA levels of the BCL-2 family 
members decrease after NGF deprivation and during 
apoptosis. Sympathetic neurons from BCL-2-deficient 
mice died more rapidly after NGF deprivation than neu- 
rons from wild-type littermates. Sympathetic neurons 
of adult animals are relatively independent of NGF for 
survival. If sympathetic neurons are maintained in 
vitro for several weeks, loss of acute trophic factor 
dependence develops with a time course similar to that 
seen in the intact animal. Examination of neurons from 
BCL-2-deficient mice showed that BCL-2 expression 
is not required for the development of trophic factor 
independence. Therefore, BCL-2 is an important regu- 
lator of the survival of sympathetic neurons after NGF 
deprivation during the period of naturally occurring 
programmed neuronal death, but BCL-2 is not involved 
in the development of trophic factor independence in 
mature sympathetic neurons. 
Introduction 
The development of the nervous system begins with the 
birth of about twice as many neurons as are finally present 
in the adult. In the sympathetic nervous system, the imma- 
ture neuronal precursors are not dependent on nerve 
growth factor (NGF) for survival (Coughlin and Collins, 
1985; Birren et al., 1993; DiCicco-Bloom et al., 1993). Sym- 
pathetic neurons then become acutely dependent on NGF 
for survival, and neurons that do not receive sufficient neu- 
rotrophic factor undergo programmed neuronal death. In 
the rat, the period of NGF dependence begins about em- 
bryonic day 19.5 (Birren et al., 1993). Following the period 
of programmed neuronal death, trophic factor depen- 
dence decreases progressively, so that adult sympathetic 
neurons are much tess acutely dependent on NGF for 
survival, but still respond to NGF with increased growth 
and will die only upon prolonged periods of trophic factor 
deprivation (Gorin and Johnson, 1980). This develop- 
mental process allows for selecting the appropriate num- 
ber of neurons to match the target size in the developing 
animal, for ridding the nervous system of inappropriate 
connections (Oppenheim, 1991), and later, for stabilizing 
the nervous system of the adult animal. Since most neu- 
rons are irreplaceable in the adult, it is imperative that 
they survive injury, such as peripheral nerve axotomy, so 
that regeneration can occur. 
The death of sympathetic neurons after NGF deprivation 
(Martin et al., 1988; Deckwerth and Johnson, 1993; Ed- 
wards and Tolkovsky, 1994) is characterized by changes 
that are apoptotic (Kerr et al., 1972), including fragmenta- 
tion of DNA into oligonucleosomes, shrinkage of the cell 
with preservation of the organelles, and blebbing in the 
cytoplasm. In many cases, apoptosis appears to be an 
active process wherein the expression of certain genes 
is required for cell death, because in sympathetic neurons 
(Martin et al., 1988) and in other cell types (Tata, 1966; 
Pratt and Greene, 1976; Cohen and Duke, 1984), the pro- 
cess can be blocked by inhibitors of RNA and protein syn- 
thesis. 
BCL-2, a mitochondrial and perinuclear membrane pro- 
tein (Hockenbery et al., 1990; Monaghan et al., 1992; Ja- 
cobson et al., 1993), and its family members BAX (Oltvai 
et al., 1993) and BCL-X (long and short forms; Boise et 
al., 1993) modulate the sensitivity of cells to death. BCL-2 
overexpression in the interleukin-3 (IL-3)-dependent B cell 
line, FL5.12, blocks death induced by trophic factor depri- 
vation; however, if, in addition, BAX is overexpressed, the 
death repressor activity of BCL-2 is antagonized. If BAX 
is overexpressed independently, death induced by IL-3 
deprivation is accelerated (Oltvai et al., 1993). The BCL-2- 
related protein, BCL-X, is produced in a long or a short 
form by alternative mRNA splicing. FL5.12 cells are pro- 
tected from death induced by trophic factor deprivation 
if BCL-XL (the long form of BCL-X) is overexpressed. In 
contrast, the short form of BCL-X, BCL-Xs, acts much like 
bax and can antagonize the protective effect of BCL-2 
overexpression (Boise et al., 1993). 
Dimerization is important for the function of BCL-2; 
BCL-2 can form homodimers with itself or can form hetero- 
dimers with BAX (Oltvai et al., 1993). Oltvai et al. (1993) 
propose that BCL-2/BCL-2 homodimers protect cells from 
death, and that BAX titrates the levels of these homodi- 
mere, rendering cells more susceptible to death. In addi- 
tion, BCL-2 binds to a number of other proteins including 
R-Ras (Fernandez-Sarabia and Bischoff, 1993); interac- 
tion with ras signal transduction pathways may be one 
mode of BCL-2 action. At least three other proteins have 
been identified that bind to BCL-2, including Nip1, Nip2, 
and Nip3 (Boyd et al., 1994). Nip1 shows homology with 
the Ca2÷/calmodulin-dependent phosphodiesterases, Nip2 
shows homology with the human GTPase-activating pro- 
tein RhoGAP, and Nip3 is a novel protein. The interaction 
of BCL-2 with Nip1, Nip2, and Nip3 may be another means 
to modify intracellular signaling processes (Boyd et al., 
1994). 
Although all of the mechanisms by which BCL-2 protects 
cells from death remain to be elucidated, a number of 
functions have been suggested. Two groups have shown 
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that BCL-2 has antioxidant properties. Hockenbery et al. 
(1993) have reported that BCL-2 overexpression in a T cell 
line blocks lipid peroxidation induced by dexamethasone 
treatment. Kane et al. (1993) have demonstrated that 
BCL-2 overexpression in a hypothalamic neural cell line 
inhibits the generation of reactive oxygen species after 
glutathione depletion with diethylmaleate. BCL-2 may also 
alter Ca 2+ fluxes. Lam et al. (1994) examined a lymphocyte 
cell line treated with thapsigargin, which inhibits the endo- 
plasmic reticulum Ca 2+ pump. Cells that overexpressed 
BCL-2 released much less Ca 2÷ into the cytoplasm, indicat- 
ing that BCL-2 reduces Ca 2÷ efflux through the endoplas- 
mic reticulum membrane. 
In addition, genetic evidence from the nematode Caenor- 
habditis elegans suggests that the worm homolog of BCL- 
2, ced-9 (Hengartner and Horvitz, 1994), functions to 
block, either directly or indirectly, the function of the puta- 
tive cysteine protease, ced-3. Functional ced-3, a protein 
that shares homology with the human cysteine protease 
IL-lJ~-converting enzyme (Yuan et al., 1993) and with hu- 
man ich-1 (Wang et al., 1994), is required for programmed 
cell death in C. elegans (Yuan and Horvitz, 1990, 1992); 
however, increased ced-9 activity overrides ced-3 activity 
and blocks cell death (Hengartner et al., 1992). The human 
Bcl-2 gene can functionally replace C. elegans ced-9 to 
block cell death in the worm (Vaux et al., 1992; Hengartner 
and Horvitz, 1994). Thus, BCL-2 either directly or indirectly 
blocks the action of ced-3. 
The developmental expression patterns of Bcl-2 in the 
CNS have been analyzed by a number of groups. Data 
at both the RNA and protein levels indicate that Bcl-2 is 
expressed at its highest levels in the prenatal brain, but 
postnatal and adult animals, including humans, express 
lower levels of Bcl-2 in the CNS (Abe-Dohmae et al., 1993; 
Castren et al., 1994; Ferrer et al., 1994; Merry et al., 1994). 
Very few studies have analyzed the expression of Bcl-2 
in the PNS. Merry et al. (1994) reported that BCL-2 protein 
expression in the prenatal mouse dorsal root ganglion 
(DRG) is retained into adulthood and that postnatal supe- 
rior cervical ganglion (SCG) neurons also express BCL-2 
protein even into adulthood. Martinou et al. (1994b) dem- 
onstrated that SCGs and DRGs from 10 week human fe- 
tuses also express BCL-2 protein. Currently, data are 
sparse regarding Bcl-2 expression during development of 
the PNS or the importance of this expression in regulating 
neuronal survival. 
Overexpression of BCL-2 in trigeminal neurons (Alisopp 
et al., 1993) or sympathetic ganglion neurons (Garcia et 
al., 1992; Greenlund et al., 1995) delays apoptosis induced 
by trophic factor deprivation. In contrast, ciliary ganglion 
neurons are not protected by BCL-2 overexpression from 
apoptosis induced by ciliary neurotrophic factor (CNTF) 
deprivation, suggesting that more than one cell death 
pathway exists within PNS neurons (AIIsopp et al., 1993). 
PC12 cells, a sympathetic neuron-like cell line, stably 
transfected with Bcl-2 are also more resistant o apoptosis 
in response to various insults (Batistatou et al., 1993; Mah 
et al., 1993). Endogenous expression of BCL-2 in sympa- 
thetic neurons clearly occurs, and overexpression of 
BCL-2 renders the neurons more resistant o death. How- 
ever, very little evidence is apparent that BCL-2 is im- 
portant for the normal regulation of sympathetic neuronal 
survival, either in the embryo, during the period of naturally 
occurring cell death, or in the adult, when neurons have 
become more resistant to trophic factor deprivation-in- 
duced death. 
We used an in vitro model (Martin et al., 1988) for the 
developmental programmed neuronal death of rat and 
mouse sympathetic neurons to examine the mRNA levels 
of the Bcl-2 family members during apoptosis. We hypoth- 
esized that immature sympathetic neurons may initiate 
apoptosis after NGF deprivation either by up-regulating 
the expression of bax or BcI-Xs or by down-regulating the 
expression of Bcl-2 or Bcl-XL. We also examined sympa- 
thetic neurons from BCL-2-deficient mice to determine 
whether BCL-2 is a regulator of neuronal survival after 
trophic factor deprivation. 
An in vitro model for the loss of acute trophic factor 
dependence that occurs with maturation in sympathetic 
neurons was used to examine the importance of BCL-2 in 
the development of this independence. We hypothesized 
that mature neurons could down-regulate the expression 
of bax and BcI-Xs or up-regulate the expression of Bcl-2 
and Bcl-XL to become more resistant o apoptosis. Sympa- 
thetic neurons from BCL-2-deficient animals were used to 
examine whether BCL-2 expression is important for the 
development of trophic factor independence. 
Lastly, we used microinjection to overexpress BCL-2 
in sympathetic neurons to determine the time course of 
survival after NGF deprivation and to examine whether 
BCL-2 overexpression could mimic the effects of NGF as 
evidenced by blocking the early fall in protein synthesis 
rates that occurs after NGF deprivation of sympathetic 
neurons (Deckwerth and Johnson, 1993). 
Results 
Immunostaining Shows BCL-2 Protein Is Present 
in Both Neurons and Nonneuronal Cells 
BCL-2 is localized in the mitochondria of lymphoid cells 
(Hockenbery et al., 1990) and in the perinuclear mem- 
brane and endoplasmic reticulum of lymphoid and other 
cell types (Chen-Levy et al., 1989; Monaghan et al., 1992; 
Jacobson et al., 1993). Merry et al. (1994), using the mono- 
clonal anti-BCL-2 antibody 3F11, have shown that in vivo 
both neurons and supporting cells in the SCG of postnatal 
day 20 (P20) mice express BCL-2. The pattern of staining 
in neurons is heterogeneous, and nuclear staining is ob- 
served. We first determined how the pattern of BCL-2 ex- 
pression in the in vitro system compared to the pattern 
of BCL-2 expression in vivo. In this system, cultures of 
dissociated rat SCG cells are prepared the day before birth 
of the animal, just before the period of naturally occurring 
neuronal death in the rat SCG (Wright et al., 1983). For 
immunostaining, dissociated SCG cells that were not pre- 
plated to remove nonneuronal cells (see Experimental 
Procedures for details) were used so that Schwann cells 
and fibroblasts would be more numerous and could be 
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Figure 1. Immunohistochemistry for BCL-2 on SCG Neurons and Supporting Cells in Culture 
Photomicrographs illustrating the pattern of BCL-2 expression in vitro for SCG neurons, Schwann cells, and fibrobiasts. After 1 week in culture, 
SCG neurons and supporting cells were stained with the 3F11 antibody r a control hamster monoclonal antibody. 
(A-C) Neurons maintained in the presence of NGF and incubated with the control antibody show no staining (A). Neurons stained with the 3Fll 
anti-BCL-2 antibody show both cytoplasmic and nuclear staining with exclusion of the nucleoli (B). After 15hr of NGF deprivation, neurons incubated 
with the 3F11 antibody show significantly less intense staining in both the nucleus and cytoplasm (C). 
(D-F) Lower power photomicrographs of invitro SCG cells, each showing two fields of cells. Neurons (open arrows) and nonneuronal cells incubated 
with a control hamster monoclonal antibody show no staining (D). In the presence of NGF, Schwann cells (small arrows), fibroblasts (large arrows), 
and neurons stained with 3Fll (E). Neurons deprived of NGF for 15 hr show much less intense staining with 3Fll (F); however, nonneuronal 
cells stained with the same intensity as in the presence of NGF. 
Bars, 15 I~m. 
clearly visualized. Rat neuronal cultures that had been 
maintained in NGF for I week were stained with the 3F11 
antibody. Immunohistochemistry showed light staining in 
both the neurons and nonneuronal supporting cells. The 
staining in the neurons was both cytoplasmic and nuclear; 
however, the nucleoli appeared to be excluded (Figures 
1A and 1B). Both Schwann cells and fibroblasts (Figures 
1D and 1 E) were also positive for BCL-2; however, staining 
was exclusively cytoplasmic in these cells. The intensity 
of staining was similar in the neurons and supporting cells, 
suggesting that BCL-2 protein levels are similar. The neu- 
ronal staining appeared uniform in the cultures; this is the 
only notable difference between the in vitro pattern and 
the in vivo pattern described by Merry et al., which shows 
heterogeneous neuronal staining. The in vitro system, 
therefore, closely mimics the in vivo situation. 
To determine how the BCL-2 protein levels or localiza- 
tion changed after NGF deprivation, sympathetic neurons 
were deprived of NGF for 15 hr and stained. By 15 hr after 
NGF deprivation, DNA fragmentation begins (Deckwerth 
and Johnson, 1993) and peak levels of gene induction 
occur for several apoptosis-associated genes (see below) 
(Freeman et ai., 1994; Estus et al., 1994). After 15 hr of 
NGF deprivation, the intensity of BCL-2 staining in the 
neurons was significantly reduced, and the nuclei no 
longer appeared to stain (Figure 1C). This is consistent 
with the observation that neuronal protein synthesis rates 
decline rapidly after trophic factor deprivation (Deckwerth 
and Johnson, 1993). No reduction in the intensity of stain- 
ing was seen in the nonneuronal cells after NGF depriva- 
tion (Figure 1F). These results suggest the possibility that 
loss of BCL-2 protein, subsequent to NGF deprivation, 
plays a role in the neuron reaching the point that it under- 
goes apoptosis. 
Expression of the BCL-2 Family Members 
Is Decreased during Apoptosis 
Since apoptosis of sympathetic neurons can be com.- 
pletely blocked by the addition of protein synthesis or RNA 
synthesis inhibitors, the expression of certain genes is 
probably important for apoptosis to proceed. Recently, 
several genes have been identified by RT-PCR that are 
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Figure 2. RT-PCR Analysis of mRNAs for 
BCL-2 Family Members during Neuronal 
Apoptosis 
In three independent experiments, preplated 
SCG neurons, after 1 week in culture, were 
deprived of NGF for the indicated number of 
hours, mRNA was isolated, and cDNA was pre- 
pared. Messages were analyzed by PCR that 
included radiolabeled CTP. Products were 
separated by SDS-PAGE and visualized by au- 
toradiography; band intensity was quantified 
by Phosphorimager analysis. A representative 
autoradiograph is shown for each message, 
and the mean and SEM for band intensity are 
plotted for the three experiments ( ingle aster- 
isk, p < .05; double asterisk, p < .01; ANOVA 
with Dunnett multiple comparisons test). 
o 10 15 20 25 30 48 0 5 10 15 20 25 30 48 
Time after NGF Deprivation (hrs) Time after NGF Deprivation (hrs) 
markedly~ induced at the transcriptional level in dying sym- 
pathetic neurons (Freeman et al., 1994; Estus et al., 1994). 
These include, among others, the G 1 to S transition regula- 
tor, cyclin D1, several Fos- and Jun-family transcription 
factors, and the transcription factor NGFI-A. We hypothe- 
sized that the BCL-2 family members may be regulators of 
the apoptotic process in sympathetic neurons. To evaluate 
gene expression in a small number of cultured sympa- 
thetic neurons, we used the semiquantitative RT-PCR 
assay characterized by Estus et al. (1994) and Freeman 
et al. (1994). A group of individual preplated cultures, each 
containing the same number of neurons, was prepared at 
a single time. These neurons were maintained in NGF for 
6 days and then deprived of NGF for a specified number 
of hours before mRNA was harvested. We began the anal- 
ysis of the BCL-2 family members by determining the num- 
ber of PCR cycles and the amount of input cDNA required 
for each set of primers to yield a linear amount of radiola- 
beled PCR product (data not shown). Using these condi- 
tions, the relative mRNA abundance of the BCL-2 family 
members during apoptosis was analyzed. In three inde- 
pendent experiments, analysis of cDNA harvested from 
neuronal cultures at given times after NGF deprivation 
showed that RNA levels for all Bcl-2 family members de- 
clined after NGF deprivation (Figure 2). The general pat- 
tern was for levels to be maintained for the first 10-15 hr 
and then decline. BcI-Xs was near the limit of detection 
in the linear range of amplification, so reliable quantified 
results could not be obtained. By 48 hr after deprivation, 
most neurons were dead and no tyrosine hydroxyiase 
message was detected; however, significant levels of 
Bcl-2 message, in particular, remained detectable. This 
is in agreement with the immunostaining for BCL-2 that 
showed a significant amount of the protein in the cultured 
nonneuronal cells. These nonneuronal cells are not sensi- 
tive to NGF deprivation and are the only cells left in the 
culture after 48 hr of NGF deprivation. It is noteworthy that 
the majority of messages analyzed after NGF deprivation 
of sympathetic neurons fall within similar time courses 
(Freeman et al., 1994; Estus et al, 1994; Greenlund et al., 
1995). This suggests that both decreased RNA synthesis 
and active RNA degradation may be important for neu- 
ronal apoptosis (Freeman et al., 1994; Estus et al., 1994) 
since under normal circumstances the mRNAs would be 
expected to have different half-lives. The decreased neu- 
ronal synthesis of the protective proteins, BCL-2 and BCL- 
XL, during apoptosis may increase the susceptibility of 
neurons to death and contribute to making the process 
irreversible. 
Sympathetic Neurons from BCL-2-Deficient Mice 
Die More Rapidly Than Neurons 
from Wild-Type Mice 
To determine unequivocally whether BCL-2 is important in 
regulating neuronal survival during the period of naturally 
occurring cell death, we examined neuronal cultures from 
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Figure 3. TimeCourseof Apoptosis in Neurons from BCL-2-Deficient, 
Heterozygous, and Wild-Type Mice 
After 1 week in culture, sympathetic neurons from wild-type (n = 5 
animals), heterozygous (n = 7 animals), or BCL-2-deficient (n = 8 
animals) mice were either maintained inNGF or deprived of NGF for 
24 or 32 hr. The live neurons in each culture were counted, and this 
number was normalized to the NGF-maintained control cultures pre- 
pared from the same mouse. After 24 hr of NGF deprivation, signifi- 
cantly fewer neurons are alive in cultures prepared from BCL-2- 
deficient mice and heterozygous mice compared with cultures 
prepared from wild-type littermates. The data show the mean and SEM 
for each set of animals (single asterisk, p< .05; double asterisk, p< .01 ; 
triple asterisk, p < .001; ANOVA with Bonferroni multiple comparisons 
test). 
mice that lack BCL-2 (Veis et al., 1993). BCL-2-deficient 
mice are the result of a mating between 2 heterozygous 
animals. Litters produced by this mating have wild-type, 
heterozygous, and BCL-2-deficient animals in them. 
These animals were sacrificed at P1 or P2 and dissected; 
tail clips were taken at the time of dissection for later geno- 
typing. Since the genotype of each animal was not known 
at the time of dissection, pairs of SCGs were removed 
from each animal, individually dissociated, and then main- 
tained separately for 1 week in the presence of NGF. At 
the time of dissociation, there was no statistical difference 
in the number of SCG neurons recovered from animals 
of the three genotypes (p > .1, ANOVA); however, after 
1 week in vitro in the presence of NGF, SCG cultures 
from BCL-2-deficient mice contained significantly fewer 
neurons than cultures from wild-type littermates (p < .05, 
ANOVA with Bonferroni multiple comparisons test). At 1 
week in vitro, SCG cultures were deprived of NGF for 24 
or 32 hr, then fixed and stained; the number of neurons 
was then counted. Crystal violet positivity and cellular mor- 
phology were used as criteria for neuronal viability (Deck- 
werth and Johnson, 1993; Franklin et al., 1995). At least 
two cultures were counted for every time point for each 
animal indicated. The data in Figure 3 show that BCL-2- 
deficient neurons (n = 8 animals) die more quickly than 
wild-type neurons (n = 5 animals), with heterozygotes 
(n = 7 animals) having an intermediate rate. Although the 
BCL-2-deficient animals do not show gross defects in the 
development of the nervous system (Veis et al., 1993), 
the data demonstrate that BCL-2 is an important regulator 
of neuronal survival under conditions of complete trophic 
factor deprivation. 
BCL-2 Family Expression and Maturation-Acquired 
Trophic Factor Independence 
To determine whether the BCL-2 family members are im- 
portant in the decreased acuteness of trophic factor de- 
pendence associated with maturation, we began by com- 
paring the mRNA levels of the BCL-2 family members from 
young neurons, which were still sensitive to NGF depriva- 
tion, with those of mature neurons. Sympathetic neurons 
that are maintained for 4 weeks in the presence of NGF 
show dramatic decreases in trophic factor dependence, 
much as they would in vivo. This in vitro model of matura- 
tion provides a controlled situation that allows a careful 
analysis of changes in gene expression as maturation pro- 
ceeds, in order that 1- and 4-week-old neurons could be 
directly compared and that the number of neurons being 
analyzed was constant, a set of individual cultures was 
prepared at one time and divided into two groups. One 
group of cultures was maintained in NGF for I week before 
harvesting RNA; the second group of cultures was main- 
tained in NGF for 4 weeks. The mature neuronal cultures 
were deprived of NGF for specific times before RNA was 
harvested. Figure 4 is a representative xperiment and 
shows that the RNA messages of most of the BCL-2 family 
members are not significantly altered as neurons de- 
crease in trophic factor dependence. The most notable 
change is the decrease in Bcl-2 mRNA in 4 week in vitro 
neurons compared with I week in vitro neurons. In contrast 
to young neurons (see Figure 2), mRNA abundance in 
mature neurons does not decrease dramatically after NGF 
deprivation. That Bcl-2 mRNA is decreased and that the 
expression of the other Bcl-2 family members is unaltered 
as trophic factor independence develops indicates that 
modulation of the expression of these genes is not the 
molecular mechanism of trophic factor independence. In 
addition, the data show that in older neurons, no longer 
acutelydependent on trophic factor, NGFdeprivation does 
not result in decreased mRNA abundance. This further 
correlates the apparent degradation and decreased levels 
of mRNA with apoptosis. 
BCL-2 Protein Is Not Up-Regulated during 
Maturation and the Acquisition of 
Trophic Factor Independence 
Using in situ hybridization in combination with immunohis- 
tochemistry, Kondo et al. (1992) and Chleq-Deschamps 
et al. (1993) have shown that BCL-2 expression may be 
regulated at the translational level. For example, germinal 
center lymphocytes express large amounts of BCL-2 mes- 
Neuron 
654 
bcl-2 
1 wk neurons 4 wk neurons 
0 0 7 15 25 48 
bax 
*--- bcl-2(23 cycles) 
*- -  tyr. h yd. (17 cycles) 
/~X / \ 
0 0 7 15 25 48 
~ *~ batx(23 cycles) 
*- -  tyr. hyd. (17 cycles) 
bcl-XL 
0 0 7 15 25 48 
~ ~ ~ '~ ~'--bcI-XL(23cycles) 
*- -  tyr, hyd.(17 cycles) 
bcI-Xs 
0 0 7 15 25 48 
,~ ~ ~ ~ .~ * - -  bcI-Xs(23 cycles) 
~ ~:  ~ *~tyr .  hyd.(17 cycles) 
Figure 4. RT-PCR Analysis of BCL-2 Family mRNAs in Mature 
Neurons 
Neurons were maintained in culture for either 1 week or 4 weeks. The 
4 week cultures were deprived of NGF for the indicated number of 
hours, mRNA was isolated from neurons and cDNA was prepared. 
SDS-PAGE was used to separate radiolabeled PCR products, and 
autoradiography was used to view the products. The number of amplifi- 
cation cycles done for each message is indicated. Note that there is 
little or no decrease in the abundance of tyrosine hydroxylase message 
or in the messages for the BCL-2 family members after NGF depri- 
vation. 
sage but little detectable BCL-2 protein, and mantle lym- 
phocytes express both message and protein (Kondo et al., 
1992). To examine whether BCL-2 protein was increased 
even though the mRNA was decreased, neurons main- 
tained 1 or 4 weeks in NGF were immunostained for BCL-2 
protein. The intensity of staining was very similar in the 
two sets of cultures (data not shown), suggesting that the 
amount of BCL-2 protein did not change with maturation. 
In addition, immunoprecipitation fol lowed by Western blot- 
ting was used to determine whether BCL-2 protein in- 
creased as neurons matured. We confirmed that the anti- 
mouse BCL-2 antibody, 3F l l ,  immunoprecipitated rat 
BCL-2 by isolating both rat and mouse thymocytes, immu- 
noprecipitating with 3F11, and separating by SDS-PAGE. 
A Western blot of thymocyte lysates from both species 
showed a 26 kDa band (data not shown). To compare the 
amount of BCL-2 in NGF-sensitive neurons with amounts 
in mature neurons, cultures containing the same number 
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Figure 5. Western Blot Comparing BCL-2 Protein in Young and Ma- 
ture Sympathetic Neurons 
Neuronal cultures were maintained in NGF for either 1 week or 4 weeks 
before harvesting. Following immunoprecipitation with 3F11 antibody, 
samples were separated by SDS-PAGE and then transferred. The 
Western blot shows an immunoprecipitation containing the 3F11 anti- 
body alone and immunoprecipitations containing 3Fll  antibody in 
combination with 1 week or 4 week neuronal lysates. Both e 1 week 
and 4 week neuronal ysates show a single 26 kDa BCL-2 band of 
similar intensity relative to the 3Fl l  band. This was repeated with 
similar results. 
of preplated neurons (the equivalent of 19 rats/culture) 
were prepared at a single time and divided into two sets. 
The first set of cultures was maintained in NGF for 1 week 
before harvesting, and the second set was maintained in 
NGF for 4 weeks before harvesting. An immunoprecipita- 
tion and Western blot with 3F l l  of both sets of lysates 
showed a 26 kDa BCL-2 band of similar or decreased 
intensity (Figure 5) in older neurons. This indicates that 
an increase in BCL-2 protein is not a factor in the loss of 
acute trophic factor dependence. 
Neurons from BCL-2-Deficient Mice Become Less 
Acutely Trophic Factor Dependent with Maturation 
Although BCL-2 levels are not increased during matura- 
tion, it is possible that the basal expression levels are nec- 
essary and sufficient for the loss of acute trophic factor 
dependence. To examine this possibility, individual pairs 
of ganglia from BCL-2-deficient, heterozygous, and wild- 
type mice were independently dissociated and maintained 
separately in NGF for 3 weeks. Cultures were then de- 
prived of NGF for 72 hr, fixed, and stained. Neurons were 
counted using crystal violet positivity and cell morphology 
as criteria for viability (Figure 6). At least two cultures per 
animal indicated were counted for each time point. No 
neuronal death occurred in any of the cultures after 3 days 
of NGF deprivation, regardless of genotype. Therefore, 
BCL-2 expression influences neuronal survival in re- 
sponse to trophic factor deprivation at the time of naturally 
occurring programmed neuronal death but is not required 
for the loss of acute trophic factor dependence in sympa- 
thetic neurons. 
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Figure 6. AnalysisofTrophicFactorlndependencein BCL-2-Deficient 
Mouse Neuronal Cultures 
After 3 weeks in culture, sympathetic neurons from wild-type (n = 4 
animals), heterozygous (n = 4 animals), or BCL-2-deficient (n = 5 
animals) mice were either maintained inNGF or deprived of NGF for 
72 hr. The live neurons in each culture were counted, and this number 
was normalized to the NGF-maintained control culture prepared from 
the same mouse. The data show the mean and SEM (p > .05 for all 
comparisons; ANOVA with Bonferroni multiple comparisons test). 
Overexpression of BCL-2 in Sympathetic Neurons 
Delays Death but Does Not Preserve 
Cellular Function 
Overexpression of BCL-2 has been reported to inhibit or 
prevent he death of many cell types in response to a num- 
ber of insults (Hockenbery et at., 1990; Garcia et al., 1992; 
Allsopp et al., 1993; Batistatou et al., 1993; Kane et al., 
1993; Zhong et al., 1993). However, closer examination 
of the data suggests that BCL-2 does not block death com- 
pletely, but rather slows the inevitable process. To exam- 
ine whether overexpression of BCL-2 would block or just 
delay the death of sympathetic neurons, we microinjected 
a human Bcl-2 expression vector or a control acZ expres- 
sion vector into the nucleus of cultured sympathetic neu- 
rons. Immunohistochemistry for human BCL-2 or X-Gal 
histochemistry for lacZ 24 hr after injection confirmed that 
96% (n = 26) of the neurons injected with the Bcl-2 expres- 
sion vector and 90% (n = 37) of the neurons injected with 
the lacZ vector were positive for the particular protein. To 
examine the effect on survival, neurons were injected with 
the Bcl-2 or lacZ expression vectors and then maintained 
in NGF for 24 hr to allow time for sufficient gene expres- 
sion. Neurons were then deprived of NGF, and the number 
of viable, injected neurons was determined at 24, 48, and 
72 hr after NGF deprivation. In five experiments, the num- 
ber of viable neurons was significantly increased by over- 
expression of BCL-2 but not by lacZ expression, although 
the Bcl-2 vector-injected neurons died over a period of 
days (Figure 7A). 
To explore further why the protection imparted by BCL-2 
was temporary, we examined whether BCL-2 would block 
the loss of cellular functions after NGF deprivation. The 
rate of neuronal protein synthesis, as assayed by [3~S]meth- 
ionine incorporation, decreases rapidly, to 20% of NGF 
control in 16-18 hr after NGF deprivation; this decrease 
can largely be prevented by K ÷ depolarization or increased 
cAMP (T. L. Deckwerth, unpublished ata), either of which 
prevents apoptosis of the neurons (Koike et al., 1989; Ry- 
del and Greene, 1988). We tested whether BCL-2 overex- 
pression would similarly block this fall in protein synthesis. 
We developed an in situ protein synthesis assay that al- 
lowed the comparison of [35S]methionine/cysteine i cor- 
poration in individual neurons. Using this assay, neurons 
that were injected and expressing the foreign gene product 
were compared with uninjected neighboring neurons. 
Cells were injected with the Bcl-2 or lacZ expression vec- 
tors, maintained in NGF-containing medium for 24 hr, and 
then deprived of NGF. After 14 hr of NGF deprivation, 
neuronal cultures were pulsed for 4 hr with [3~S]methio- 
nine/cysteine. After exposure to emulsion, the number of 
grains overlaying neurons was counted under dark-field 
microscopy (Figures 7B and 7C). When injected neurons, 
maintained in NGF, were compared with uninjected neigh- 
boring cells, the number of grains overlaying the neurons 
did not differ (lowest p > .2, Student's t test; Figure 7C), 
irrespective of the vector injected. Thus, the rate of 
[3sS]methionine/cysteine incorporation and overall rates 
of protein synthesis were unaffected by the injection pro- 
cess. Neurons deprived of NGF (18 hr total) had, on aver- 
age, 79% fewer silver grains over them than those main- 
tained in NGF (Figure 7C). In NGF-deprived cultures, 
neurons overexpressing BCL-2 (Figure 7B) or LacZ (data 
not shown) had no difference in the number of grains over- 
laying them compared with uninjected neighboring neu- 
rons (lowest p > .4, Student's t test; Figure 7C).. Therefore, 
the dramatic decrease in protein synthesis that occurs with 
NGF deprivation is not prevented by BCL-2 overexpres- 
sion. Because this crucial cellular function is not main- 
tained by the expression of BCL-2, it is not surprising that 
injected neurons do not remain viable for a prolonged pe- 
riod. The failure of BCL-2 to maintain protein synthesis 
rates indicates that, although the loss of viability is re- 
tarded, BCL-2 does not prevent he loss of cellular function 
associated with NGF deprivation-induced death in sympa- 
thetic neurons. 
Discussion 
Overexpression of BCL-2 in neurons or neuron-like cell 
lines protects cells from apoptosis in response to a number 
of death-inducing stimuli (Garcia et al., 1992; AIIsopp et 
al., 1993; Mah et al., 1993). Recently, Martinou et al. 
(1994a) have produced transgenic mice that overexpress 
BCL-2 in the nervous system. These mice have a reduced 
number of neuronal deaths in both the retina and facial 
nucleus during the period of programmed neuronal death, 
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Figure 7. BCL-20verexpression Delays Neuronal Apoptosis but Does Not Block the Fall in Protein Synthesis Rates That Occurs after NGF 
Deprivation 
(A) After 5-6 days in culture, sympathetic neurons were injected with the Bcl-2 (n = 300) or lacZ (n = 382) expression vector and maintained in 
NGF for 24 hr. All cultures were then deprived of NGF for the indicated number of hours. The mean and SEM for five experiments are shown. 
(B) The left column shows photomicrographs of phase-contrast images of injected (large arrows) and noninjected (small arrows) neurons in the 
presence and absence of NGF. The middle column shows fluorescent images of the same fields of neurons; injected neurons were identified by 
the presence of the fluorescent label within the cell (identified by large arrows). The right column shows the in situ protein synthesis assay with 
silver grains overlaying neurons. Note that expression of BCL-2 had no effect on methionine incorporation in either the presence of absence of 
NGF. Bar, 25 pm. 
(C) Quantification of grains over injected versus uninjected neurons in the presence or absence of NGF. There is no statistical difference in the 
number of grains overlaying neurons overexpressing BCL-2 (hatched bars; n = 17) or uninjected neurons (closed bars; n = 17) in the presence 
of NGF (p > .2, Student's t test). The inset shows the average number of grains counted per neuron for each condition and the total number of 
grains counted. The data are normalized to the NGF-maintained cells, injected or uninjected. After a total of 18 hr of NGF deprivation, the number 
of grains over neurons is decreased by an average of 79%. BCL-2-overexpressing neurons (n = 28) show the same decrease in grain density 
as uninjected neighboring neurons (n = 28). The data are the mean grain counts and SEM of all neurons in two independent experiments. 
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as well as reduced neuronal death after experimental 
stroke. Although BCL-2 overexpression clearly affects 
neuronal survival, the importance of endogenous BCL-2 
has not been assessed. We examined, in a well-char- 
acterized in vitro system, the physiological importance of 
endogenous BCL-2 in regulation of neuronal survival, 
function, and maturation. 
BCL-2 and Maturation-Induced Trophic 
Factor Independence 
Using RT-PCR, we determined whether the loss of acute 
trophic factor dependence in mature neurons was corre- 
lated with changes in BCL-2 family member gene expres- 
sion. The mRNA levels for most Bc/-2 family members 
were not significantly altered, and there was a decrease in 
Bc/-2 message abundance with the development of trophic 
factor independence. In addition, immunostaining and 
Western blots show no increase in BCL-2 protein with mat- 
uration. Examination of neurons from BCL,2-deficient 
mice demonstrates that BCL-2 expression was not re- 
quired for the loss of acute trophic factor dependence. 
Thymocyte (Moore et al., 1994) and B cell (Merino et al., 
1994) development each involve stage-specific regulation 
of BCL-2 expression. Pro-B cells express high levels of 
BCL-2, but pre-B and immature B cells express only low 
levels. Those B cells that reach maturity express high lev- 
els of BCL-2 (Merino et al., 1994), which is important for 
maintaining memory B cells for prolonged periods (NuSez 
et al., 1991). The susceptibility of B cells at various stages 
of development to apoptosis-inducing stimuli, such as glu- 
cocorticoid treatment, correlates positively with the levels 
of BCL-2 expression (Merino et al., 1994). A similar devel- 
opmental process in which the BCL-2 family members reg- 
ulate the sensitivity of sympathetic neurons to NGF depri- 
vation does not appear to occur. It is noteworthy that in 
mature neurons the decrease in mRNA abundance after 
NGF deprivation does not occur, indicating that the initia- 
tion of degradative vents after NGF deprivation is greatly 
slowed in mature neurons. The molecular mechanism un- 
derlying loss of acute trophic factor dependence has yet 
to be elucidated. Understanding the mechanisms of resis- 
tance to apoptosis in the absence of trophic factor may 
prove to be important in understanding both apoptosis 
and disease states in which neurons are inappropriately 
susceptible to death. 
BCL-2 and Neuronal Survival during the Period of 
Programmed Neuronal Death 
Again by using RT-PCR, we examined mRNA for the 
BCL-2 family members in neurons undergoing apoptosis. 
Bcl-2 and Bcl-Xt_ mRNA levels decreased after 15 hr of 
NGF deprivation; at 15 hr, neurons can be rescued from 
death by addition of NGF (Deckwerth and Johnson, 1993). 
Thus, this fall in rnRNA levels was not caused by the loss 
of neurons and most likely reflects active RNA degradation 
combined with decreased RNA synthesis. Immunostain- 
ing of NGF-deprived neurons also showed a significant 
decrease in BCL-2 protein by 15 hr after NGF deprivation. 
The reported half-life for BCL-2 protein is 10 hr (Merino 
et al., 1994); since protein synthesis rates decline rapidly 
after NGF deprivation, at least half of the BCL-2 protein 
would be expected to be gone by 15 hr after NGF depriva- 
tion, an observation consistent with the immunohisto- 
chemical data. The decreased levels of BCL-2 and BCL-X, 
after NGF deprivation, coupled with increased levels of 
cyclin D1 and several Fos/Jun family transcription factors, 
may be important in creating a cellular environment that 
irreversibly commits a neuron to die. Experiments with 
neurons from BCL-2-deficient mice demonstrate that elim- 
ination of BCL-2 expression significantly increased the 
rate at which neurons die in response to trophic factor 
deprivation. Similarly, when Nakayama et al. (1993) and 
Veis et al. (1993) evaluated the effect of the death-inducing 
stimuli, dexamethasone and ~, irradiation, on T cells of 
BCL-2 homozygous mutant mice (chimeras and complete 
knockouts, respectively), they observed an increased sus- 
ceptibility to death. The BCL-2-deficient mice do not show 
gross developmental defects In the nervous system (Veis 
et al., 1993). This may be explained by the redundant ac- 
tion of BCL-XL or similar molecules. In addition, in this 
in vitro paradigm, neurons were deprived completely of 
trophic factor. Under these extreme conditions, the lack 
of BCL-2, or the presence of only a single copy, increases 
the rate of death and may increase the susceptibility to 
death induced by a variety of insults. The in vitro conditions 
used in these experiments may be more akin to axotomy 
or other injury paradigms in which neurons are more com- 
pletely deprived of trophic factor. During development, 
neurons receive some target-derived or other trophic sup- 
port and are not completely deprived of trophic factor; 
under these conditions, molecules in addition to BCL-2, 
such as cell-cell/matrix contacts, and electrical activity 
may all function to support neuronal viability. Under more 
extreme conditions, the lack of one or more of these could 
lead to increased susceptibility to death. Based on the in 
vitro results, one would predict that ganglia of BCL-2- 
deficient mice would have more neuronal death in re- 
sponse to axotomy or target removal. That endogenous 
BCL-2 levels decrease shortly before neurons are irrevers- 
ibly committed to die and that neurons from BCL-2- 
deficient mice die much more rapidly suggest that a de- 
crease in endogenous neuronal BCL-2 levels increases 
the susceptibility of neurons to death, and as such, this 
decrease is an important factor in the neuron becoming 
committed to die. These observations upport previous 
speculations (Estus et al., 1994) that the "program" in pro- 
grammed neuronal death involves not only increased ex- 
pression of certain genes but also decreased expression 
of others. 
Where Does BCL-2 Act to Block Programmed 
Neuronal Death? 
Overexpression of BCL-2 in sympathetic neurons signifi- 
cantly delayed, but did not block, apoptosis after NGF 
deprivation; nor did it block the early fall in protein syn- 
thesis rates that occurs in NGF deprivation-induced 
apoptosis. This is in contrast o other agents, K + depolar- 
ization or increased cAMP, that maintain viability after tro- 
phic factor deprivation. Since protein synthesis rates are 
not maintained by BCL-2, the expression of BCL-2 itself 
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would be expected to fall, and BCL-2 would no longer be 
overexpressed. This loss of BCL-2 protein, and the global 
decrease in cellular protein synthesis, contributes to mak- 
ing BCL-2 only a temporary saving agent. 
Raft and colleagues (Jacobsen et al., 1994) propose that 
apoptosis is a multistep process consisting of an activation 
phase, an effector phase, and a degradation phase. We 
would suggest a somewhat modified scheme of pro- 
grammed cell death involving an activation phase, fol- 
lowed by a propagation phase, a terminal apoptotic phase, 
and, at least in vivo, a degradation phase. In sympathetic 
neurons, the activation phase of NGF deprivat ion- induced 
death involves the expected dephosphorylat ion of the 
TrkA receptor (C. Sanz-Rodriguez, unpublished data), de- 
creased MAP kinase activity (D. J. Creedon, submitted), 
and the increased formation of reactive oxygen species 
(Greenlund et al., 1995). These events trigger processes in 
the propagation phase that include positive and negative 
regulation of gene expression and other biochemical 
changes within the cell. RNA levels for genes including 
c-jun, c-fos, and cyclin D1 are markedly increased, while 
RNA levels for Bcl-2 and Bcl-XL are decreased during the 
propagation phase. A portion of the negative regulation 
of RNA levels may be explained by an active degradation 
of RNA. In addition, the synthesis of new protein and RNA 
is dramatically decreased during the propagation phase. 
The terminal apoptotic phase includes events that abso- 
lutely commit a neuron to die, i.e., the fragmentation of 
DNA into ol igonucleosomal fragments and, potentially, the 
activation of a ced-3-1ike cysteine protease (Yuan et al., 
1993). 
To what extent BCL-2 is capable of reversing the events 
associated with the activation and propagation phases 
outlined above is not known. Our data suggest that, since 
BCL-2 overexpression does not block the fall in neuronal 
protein synthesis rates (even though it clearly prolongs 
viability), BCL-2 may be an effective blocker of the terminal 
apoptotic phase during which killing actually takes place 
but not of events in the activation or propagation phase. 
Albrecht et al. (1994) observed a similar phenomenon in 
analyzing BCL-2 protection from tumor necrosis factor 
(TNF)- induced apoptosis. TNF treatment normally stimu- 
lates the translocation of NF-KB to the nucleus of L929 
cells before apoptotic changes are evident. Although L929 
cells that overexpress BCL-2 are protected from death 
induced by TNF, NF-KB is still translocated after TNF treat- 
ment. Whether overexpression of BCL-2 in sympathetic 
neurons would block the alterations in gene expression 
of the propagation phase is not known. However, the ability 
of BCL-2 to block apoptosis induced by a myriad of stimuli, 
including those showing no lag phase and no requirement 
for ongoing macromolecular synthesis (e.g., serum depri- 
vation of PC12 cells; Batistatou et al., 1993), is most con- 
sistent with an action at, or immediately prior to, the termi- 
nal apoptotic phase. This may include a direct or indirect 
interaction of BCL-2 with a ced-3-1ike molecule. Under- 
standing the events in this process will provide means not 
only for prolonging neuronal viability in injury or disease 
but also for preserving neuronal function. 
Experimental Procedures 
Rat Sympathetic Neuronal Culture 
Primary cultures of SCG neurons were prepared by a modification 
(Martin et al., 1988) of the method of Johnson and Argiro (1983). For 
preplating, dissociated SCG cells were plated on untreated 60 or 100 
mm Falcon (Becton Dickinson Labware, Lincoln Park, N J) tissue cul- 
ture dishes for 90 min, enough time for most of the nonneuronal cells 
to attach to the plastic; however, neurons require a collagen (or other) 
substratum for attachment and remained floating. The floating neu- 
ronal cells were carefully washed off the plastic dish, filtered through 
Nitex (size 3-20/14; Tetko Inc., Gaithersburg, MD) to remove aggre- 
gates of neurons, and then plated. Neurons were plated in the center 
of collagen-coated 35 mm dishes and maintained in NGF-containing 
medium (AM50). AMS0 was Eagle minimal with Earle's salts (MEM; 
Life Technologies, Gaithersburg, MD), with the addition of 50 ng/ml 
NGF (prepared by the method of Bocchini and Angeletti [1969]), 10% 
fetal bovine serum (Hyclone, Logan, UT), 2 mM L-glutamine, 100 p.g/ 
ml penicillin, 100 p.g/ml streptomycin, 20 ~M fluorodeoxyuridine (an 
antimitotic), and 20 ~M uridine. Neurons were deprived of NGF by 
incubation in the same medium, but without NGF (AM0) and with goat 
polyclonal anti-mouse NGF antiserum added. 
Immunostaining 
To stain for endogenous BCL-2, neurons were fixed in fresh 4O/o para- 
formaldehyde in phosphate-buffered saline (PBS) at room temperature 
for 30 rain, permeabilized for 20 min in Tris-buffered saline (TBS) con- 
taining 0.1% Triton X-100, 1% BSA, and 1% normal goat serum, and 
then incubated with the primary antibody, 3F11 hamster monoclonal 
anti-mouse BCL-2 (1:20; 50 i~g/ml final concentration) (Merry et al., 
1994), or a control 6C8 hamster monoclonal anti-human BCL-2 anti- 
body (1:20; 50 ~g/ml final concentration) (Hockenbery et al., 1990) 
diluted in the permeabilization solution. Incubation with the primary 
antibody was for 1.5 hr at room temperature. Samples were rinsed 
twice and then washed three times for 10 rain in permeabilization 
solution. The biotinylated goat anti-hamster secondary antibody (South- 
ern Biotechnology, Birmingham, AL) was diluted 1:100 (5 t~g/ml final 
concentration) in permeabilization solution and incubated for 30 min 
at room temperature with the samples. After three 10 rain washes in 
PBS, samples were incubated for 30 rain in ABC reagent (avidin-HRP; 
Vector Laboratories, Burlingame, CA). After three 15 rain washes in 
PBS, samples were stained for 5-7 min with 3,3'-diaminobenzidine 
(Vector Laboratories). To detect overexpressed human BCL-2, neu- 
rons were stained as described above, but the primary antibody was 
1:100 (10 t~g/ml) 6C8 hamster monoclonal anti-human BCL-2. The 
biotinylated secondary antibody and staining procedures were the 
same as those described above. 
cDNA Preparation 
This method and its validation have been described previously (Estus 
et al., 1994). Primary cultures (-25,000 neurons/dish) that had been 
preplated on plastic were maintained in AM50 for 6 days. Cultures 
were deprived of NGF for the indicated times, and then RNA was 
harvested. Polyadenylated RNA was isolated using an oligo(dT)- 
cellulose mRNA purification kit as directed by the manufacturer 
(QuickPrep Micro kit, Pharmacia, Piscataway, N J). Half of the poly(A) 
RNA was converted to cDNA by reverse transcription with Moloney 
murine leukemia virus reverse transcriptase (Superscript, Life Tech- 
nologies) with random hexamers (16 I~M) as primers. The 30 p.I reaction 
contained 50 mM Tris (pH 8.3), 40 mM KCI, 6 mM MgCI2, 1 mM dithi- 
othreitol, 500 I~M dATP, 500 p.M dTTP, 500 I~M dCTP, 500 I~M dGTP, 
and 20 U of RNasin (Prornega, Madison, WI). After 10 min at 20°C, 
the samples were incubated for 50 min at 42°C; the reaction was 
terminated by adding 70 p.I of water and heating to 94°C for 5 rain. 
PCR Analysis 
For a more detailed description of this method, see Freeman et al., 
1994; Estus et al., 1994; or Greenlund et al., 1995. Oligonucleotide 
primers were synthesized by the Washington University Protein Chem- 
istry Laboratory. Reactions for PCR amplification of specific cDNAs 
were prepared on ice. Each reaction contained 50 I~M dCTP, 100 p.M 
dGTP, 100 I~M dATP, 100 ~M dTTP, 15 p.Ci of [~-32P]dCTP (3000 Ci/ 
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mmol), 1.5 mM MgCI~, 50 mM KCI, 10 mM Tris (pH 9.0), 0.1% Triton 
X-100, 1 mM each primer, 1 U of Taq polymerase (Life Technologies), 
and 1% of the cDNA synthesized in the reverse transcription reaction. 
Each reaction was run for cycles of 1 min at 94°C, 1 min at 55°C, 
and 2 min at 72°C in a Perkin-Elmer Cetus (Norwalk, CT) thermocycler. 
After amplification, products were separated on a 10% polyacrylamide 
gel, which was dried and visualized with ImageQuant software on 
a Phosphorlmager (Molecular Dynamics, Sunnyvale, CA). The Bcl-2 
forward primer sequence was 5'-CTTTGTGGAACTGTACGGCCC- 
CAGCATGCG-3'; the reverse was 5'-ACAGCCTGCAGCTTTGTTT- 
CATGGTACATC-3' (the pair generated a 231 bp fragment). The bax 
forward primer sequence was 5'-GGGAATTCTGGAGCTGCAGAG- 
GATGATT-3'; the reverse was 5'-GCGGATCCAAGTTGCCATCAG- 
CAAACAT-3' (the pair generated a 96 bp fragment). The rat Bcl-X 
forward primer was 5'-AGGCTGGCGATGAGTTTGAA-3'; the reverse 
was 5'-CGGCTCTCGGCTGCTGCATT-3' (the pair generated a 337 
bp fragment for the long-form cDNA and a 150 bp fragment for the 
short-form cDNA). The tyrosine hydroxylase forward primer was 
5'-TTCAGAAGGGCCGTCTCAGA-3'; the reverse was 5'-CCGCTGCT- 
GCTGCTGCAGCT-3' (the pair generated a 129 bp fragment). The 
Bcl-2 and bax primers were based on mouse sequence, so the prod- 
ucts were subcloned and sequenced to confirm their identity. The 
Bcl-X primers were based on rat sequence and generated only two 
products, both of the expected size. The decrease in message abun- 
dance after NGF deprivation was tested in at least three independent 
sets of cDNA for all messages. The analysis of message abundance 
with maturation was tested in four sets of cDNA for BcI-X (five indepen- 
dent experiments), two sets for Bcl-2 (five independent experiments), 
and one set for bax (two independent experiments). 
Preparation of SCG Cultures and Genotyping 
from BCL-2-Deficient Litters 
Mice (Veis et al., 1993) were dissected on P1 or P2. The geneotype 
of each animal was unknown at the time of dissection, so the pairs 
of ganglia from each animal were individually dissociated and plated 
on collagen-coated glass chamber slides. At least two cultures were 
prepared for every data point for each animal. The final cultures con- 
tained - 1000 neurons/well. The medium and culture conditions were 
the same as those described above for rat neuronal cultures. Geneo- 
typing was done by digesting the tail of each animal overnight at 55°C 
in 250 I11 of a solution containing 50 mM KCI, 10 mM Tris-HCI, 1 mM 
EDTA (pH 8.0), 0.5% SDS, and 2 mg/ml proteinase K (Boehringer 
Mannheim, Indianapolis, IN). Samples were centrifuged to remove 
large debris, and 150 ~1 of the supernatant was transferred to fresh 
tubes. After 250 Id of a solution containing 100 mM NaCI, 10 mM Tris- 
HCI (pH 8.0), 1 mM EDTA (pH 8.0), 0.5% SDS, and 1 mg/ml RNase 
A (Boehringer Mannheim) was added to the tail digest samples, they 
were incubated at 37°C for 1 hr. DNA was extracted twice with phenol/ 
chloroform and once with chloroform and was then precipitated with 
ethanol. The resulting DNA was diluted 1:10 and 1 I11 was used in a PCR 
reaction to determine geneotype. Reactions for PCR amplification of 
specific cDNAs were prepared on ice. Each reaction contained 50 I~M 
dCTP, 100 I~M dGTP, 100 pM dATP, 100 ~M dTTP, 1.5 mM MgCI2, 
50 mM KCI, 10 mM Tris (pH 9.0), 0.1% Triton X-100, 1 mM each primer, 
1 U of Taq polymerase (Life Technologies), and 1 i11 of the dituted tail 
DNA. Each reaction was run for 35 cycles of 1 min at 94°C, 1 min at 
55°C, and 2 rain at 72°C. The primers used to detect Bcl-2 were the 
same as those stated above. The forward primer for the detection of 
the neomycin resistance gene was: 5'-GGATCGGCCATTGAACAA- 
GATG-3'; reverse primer was 5'-CCGGGCGCCCCTGCGCTGACAGC- 
3' (the pair generated a 141 bp fragment). 
Crystal Violet Staining and Neuronal Counting for Transgenic 
Mouse Experiments 
This method is established as a reliable assay of viability (Deckwerth 
and Johnson, 1993; Franklin et al., 1995). Neuronal cultures on glass 
chamber slides were fixed with freshly prepared 4% paraformaldehyde 
in PBS overnight at 4°C, stained with 1% crystal violet (EM Diagnostic, 
Gibbstown, NY), destained in water, dehydrated in increasing ethanol 
concentrations, transferred to toluene, and mounted in a toluene- 
based mounting solution (Pro-Texx; Baxter Diagnostics, Deerfield, IL). 
Neurons were scored as viable if they had a defined cellular outline 
and visible nucleolus. Slides were coded and counts were done by 
an independent observer. 
Immunoprecipitation and Western Blots 
Preplated cultures of rat SCG neurons were prepared as described. 
The equivalent of 38 ganglia (3.7 x 10 s preplated neurons) were plated 
per 60 mm dish, and one dish was used per immunoprecipitation. 
After 1 or 4 weeks in culture, neurons were lysed in 250 i~1 of buffer 
containing 1% Triton X-100 (Sigma Chemicals, St. Louis, MO), 0.15 
M NaCI, 10 mM Tris (pH 7.4), 50 p.g/mt phenylmethylsulfonyl f uoride 
(Boehringer Mannheim), 10 i~g/ml aprotinin (Boehringer Mannheim), 
and 10 I~g/ml leupeptin (Boehringer Mannheim). The plates were incu- 
bated on ice for 30 min followed by scrapping to maximize recovery. 
Lysates were centrifuged at 13,000 rpm for 5 min to remove large 
cellular debris and nuclei. For each immunoprecipitation, 3 ~1 of 1 mg/ 
ml 3F11 antibody was used. Samples were incubated for 1 hr at 4°C 
on a rocker with the antibody. Protein G Sepharose in PBS (50 i11) 
was added to each sample followed by another 1 hr incubation at 4°C 
on a rocker. The beads were then washed five times in the lysis buffer 
to reduce nonspecific binding. On the last wash, all buffer was removed 
and reducing sample buffer containing 50 mM Tris-CI (pH 6.8), 100 
mM dithiothreitol, 2% SDS, 0.1% bromphenol blue, and 10% glycerol 
was added to each reaction. Samples were boiled and loaded onto a 
15% SDS-polyacrylamide gel. After electrophoresis, gels were trans- 
ferred to Immobilon-P (Millipore, Bedford, MA). Blots were blocked 
overnight in TBS plus 5% nonfat dry milk, washed in TBS plus 0,05% 
Tween-20 (TBST), and then incubated with a 1:1000 (1 t~g/mt final 
concentration) dilution of 3F11 antibody in TBST for 45 min at room 
temperature. After thorough washing, blots were incubated with 1: 
1000 (0.5 t~g/ml) biotinylated goat anti-hamster antibody (Southern 
Biotechnology) in TBST for 30 min at room temperatu re. After washing, 
blots were incubated with 1:5000 avidin-HRP (Zymed, San Francisco, 
CA) in TBST for 15 rain at room temperature. Blots were developed 
by enhanced chemiluminescence according to the manufacturer's in- 
structions (Amersham, Arlington Heights, IL). 
Construction and Injection of Expression Vectors 
The base expression vector was constructed by cloning into pUC19 
a 695 bp hCMV IE-1 promoter (620 bp upstream of the transcription 
start site and 75 bp downstream; Boschart et al., 1985) and a 355 bp 
portion of the mouse protamine-1 gene (Kleene et al., 1985) including 
the polyadenylation signal. Specific expression vectors were con- 
structed by cloning cDNAs into the BamHI site between the promoter 
and polyadenylation signal of the base vector. The Bcl-2 cDNA was 
a 1.9 kb fragment, clone #58 (Seto et al., 1988), containing the entire 
coding region for human BCL-2. DNAwas prepared by column purifica- 
tion (Qiagen, Chatsworth, CA) and resuspended at 0.18 mg/ml in ster- 
ile-filtered, deionized water. For injections, DNA was combined 1:1 
with a dye solution containing 8 mg/ml rhodamine dextran, 100 mM 
KCI, and 10 mM K3PO4, so that the final DNA concentration injected 
was 0.09 mg/ml. Neuronal culture medium was changed to Leibovitz's 
L-15 (Life Technologies), and injections were made into the nucleus 
of each neuron. Concentrations of DNA above 0.5 mg/ml produced a 
delay in apoptosis irrespective of the cDNA in the vector. We demon- 
strated by the in situ protein synthesis assay (see below) that injection 
of DNA at concentrations as low as 0.2 mg/ml occasionally caused 
an inhibition of protein synthesis in the presence of NGF, which pre- 
sumably explains the delay in death. Experiments were scored by an 
independent observer. 
In Situ Protein Synthesis Assay 
This method has been described previously (Greenlund et al., 1995). 
In brief, neurons were injected with solutions containing 0.09 mg/ml 
expression vector DNA, 2.25 mg/ml Cy3-1abeled donkey anti-sheep 
antibody as a fixable tracer (Chemicon, Temecula, CA), 50 mM KCI, 
and 5 mM K3PO4 and then maintained in AM50 for 24 hr. Cultures 
were deprived of NGF for 14 hr before beginning a 4 hr labeling period. 
During the labeling period, neurons were incubated at 35°C in Eagle 
medium with Earle's salts and 10% fetal bovine serum containing 10 
~M unlabeled L-methionine and cysteine, 10 ~Ci/ml Tran[3SS]-Iabel 
(ICN, Irving, CA), and 50 ng/ml NGF or polyclonal goat anti-NGF anti- 
body. After labeling, cultures were washed and fixed in 4% paraformal- 
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dehyde. Cells were dehydrated and dipped in Kodak emulsion (Kodak, 
Rochester, NY). After an overnight exposure, dishes were developed 
in D-19 developer (Kodak), fixed, and rinsed. Grains lying within the 
borders of the cell body of each neuron were counted by an indepen- 
dent observer under dark-field microscopy. 
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